Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Biosensors Buys China Stent Maker

publication date: Jan 10, 2008

Biosensors International Group announced plans to buy the 50% of JW Medical Systems Ltd (JW Medical) that it does not already own. Like Biosensors, JW Medical produces drug-eluting stents (DESs). JW Medical currently controls between 25% and 30% of the $400 million market in China for DESs. Biosensors will exchange 160 million shares for the 50% stake in JW Medical, making the transaction worth about $109 million. The 160 million shares that Biosensors would pay for 50% of JW Medical are about two times revenues. More details...

Stock Symbol: (SGX: B20)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here